Back

Hogan Lovells Cadwalader advises Gedeon Richter on pending acquisition of Mayne Pharma

New York, 19 November 2026 – Global law firm Hogan Lovells Cadwalader is advising Gedeon Richter, a company committed to advancing women’s health that is headquartered in Hungary, in its entrance into a Scheme Implementation Deed (“SID”) to acquire Mayne Pharma Group Limited (ASX:MYX) (“Mayne Pharma”), a specialty pharmaceutical company focused on commercializing novel pharmaceuticals in women’s health in the United States.

Under the terms of the agreement, Gedeon Richter has agreed to acquire 100% of the shares in Mayne Pharma by way of a Scheme of Arrangement (“Scheme”) at a price of AUD 6.40 per share, which values Mayne Pharma’s equity at approximately AUD 604 million.

“This transaction is a terrific example of the cross-border and cross-practice expertise our team brings to bear on sophisticated multijurisdictional transactions,” said partner Greg Patti. “By bringing together colleagues across jurisdictions and disciplines, we’ve been able to provide Gedeon Richter with seamless, coordinated advice in negotiating a complex strategic acquisition.”

More information on the transaction can be found here.

The Hogan Lovells Cadwalader cross-practice deal team was led by partner Gregory Patti (M&A, New York) and associates Christal McCamy and Olivia Maraj (both M&A, New York). Additional team members included partners Global Head of M&A Elizabeth Donley (Washington, D.C.), Scott Campbell (Real Estate, Denver), Robert Church (Pharmaceuticals & Biotechnology, Los Angeles), Kristin Connarn (IP, Boston), Brian Curran (International Trade & Investment, Washington, D.C.), David Fox and Komal Nigam (both Pharmaceuticals & Biotechnology, Washington, D.C.), Michael Frese (Antitrust & Competition, Brussels), Andrew O’Brien (Tax, Pensions & Benefits, New York), Joy Sturm (Government Contracts & Education, Washington, D.C.) and Allison Wuertz (Litigation, New York); senior attorney Adam Keller (Real Estate, Denver); counsel Bilal Sayyed (Antitrust & Competition, Washington, D.C.), Laura Hunter and Kathleen Peterson (both Health, Washington, D.C.), Mitra Anoushiravani (Employment, New York), and Stefan Kirwitzke (Antitrust & Competition, Brussels); senior associates Eman Al-Hassan (Pharmaceuticals & Biotechnology, Los Angeles), Will Tenbarge (Pharmaceuticals & Biotechnology, Washington, D.C.), Mahmud Brifkani (Health, Washington, D.C.), and Patrick Miller (International Trade & Investment, Washington, D.C.); associate Etienne Durand (Antitrust & Competition, Brussels); and trainee solicitor Shenaya Lalljee (M&A, New York).

LEGAL DESIRE NEWSLETTER

Where the legal industry reads first.

Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.

No spam. Unsubscribe anytime.

From Legal Desire

Is your firm the one being cited, or the one being skipped?

We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.

Lawyers and firms: get featured on Legal Desire

Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.

Get featuredSubmit a press release
See the full deal record on DealDatabase
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
Cynthia Lydia Marbaniang
Associate & Staff Writer